ZUBEREITUNG MIT ROSIGLITAZON UND METFORMIN
European patent · EP1663191 · Deleted
Register entry
- Publication number
- EP1663191
- Application number
- EP04741403
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Aug 9, 2004
- Published
- Jun 7, 2006
- Granted
- Jan 20, 2010
- Deleted
- Aug 31, 2013
- Reason
- Annual fee unpaid
- IPC classes
- A61K 31/155 (2006.01)A61K 31/4439 (2006.01)A61K 9/28 (2006.01)A61P 3/10 (2006.01)
- Priority
- GB 0318824 11.08.2003
- PCT application
- PCT/EP2004/008970 09.08.2004
- PCT publication
- WO2005/013956 17.02.2005
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 19, 2014
Deleted, fee unpaid
Published in Swissreg on 19.03.2014
- Jan 20, 2010
Granted
Published in Swissreg on 20.01.2010
Parties
Inventor
COLES, Peter John, GlaxoSmithKline Inc.
Mississauga, Ontario L5N 6L4, CA
MACKENZIE, Donald Colin, GlaxoSmithKline (CIDRA)
King of Prussia Pennsylvania 19406, US
MUDD, Paul Norman, Jr., GlaxoSmithKline
Research Triangle Park, NC 27709, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.